论文部分内容阅读
Rosiglitazone(RZ)和Pioglitazone(PZ)治疗2型糖尿病都很安全且耐受性较好。然而,美国德克萨斯州立大学糖尿病研究所的研究人员对于此药的使用则很谨慎,因为糖尿病患者始终处于冠状动脉疾病风险之中,医生在选择特异性thiazodenedione类药时应考虑不同药物对血脂水平的影响。
Rosiglitazone (RZ) and Pioglitazone (PZ) are safe and well-tolerated for type 2 diabetes. However, researchers at the Texas State University Institute of Diabetes are cautious about the use of this medicine because people with diabetes are at risk of coronary artery disease and physicians should consider different combinations of drugs when choosing specific thiazodenedione drugs Effect of blood lipid levels.